A Team That Pushes Boundaries

Marty Tenenbaum is a renowned computer scientist, Internet entrepreneur and cancer survivor. He founded Cancer Commons and CollabRx (NASD: CRLX) to help each cancer patient obtain the best possible outcome. He is an Internet commerce pioneer and visionary, having founded EIT (1990) and CommerceNet (1994) to accelerate business use of the Internet, and later, was an officer and director of Commerce One, Webify Solutions (sold to IBM in 2006), and Medstory (sold to Microsoft in 2007). Dr. Tenenbaum is a fellow and former board member of the American Association for Artificial Intelligence, and a former Director of Patients Like Me. Dr. Tenenbaum holds BS and MS degrees in Electrical Engineering from MIT, and a PhD from Stanford, and has received numerous awards for his work in AI and as a patient advocate.

Mika Newton has over twenty years of leadership experience in the life sciences. Most recently he was the Chief Commercial Officer of Doctor Evidence, LLC. Prior to Doctor Evidence he was the General Manager of Clinical Development Services at diaDexus, SVP of Client and Market Development at Evidera, VP of Sales and Marketing at Archimedes, and held sales management and sales operations roles at Quintiles, Invitrogen and Tripos.

Katie Chudnovsky is the general counsel for a national privately-held technology firm. She also has her hands in numerous other projects, investing and providing support for a telehealth start-up, a private healthcare organization and a helicopter airport. Chudnovsky is passionate about philanthropy, and in addition to providing major donations to a number of universities and research hospitals she is also president of the board of directors for a large non-profit.

Moe Kermani is a Managing Partner of Vanedge Capital where he focuses on investments in Cloud computing, Artificial Intelligence, Cybersecurity, Analytics, and Quantum Information. Prior to that he was President and CEO of Bycast Inc., a world leader in object storage that was successfully acquired by NetApp. Moe has extensive experience working with entrepreneurial companies and taking to market leading-edge technology products. He holds a PhD in physics from the University of British Columbia.

Dr. Marton serves as a consultant to industry and to nonprofit, government, and academic institutions. In the nonprofit sector, Dr. Marton is an Emeritus Member of the   Board of Trustees of the American Association for Cancer Research Foundation and is on the Board of Directors of Cancer Commons.  In the for-profit sector, he serves on the Boards of Directors of Cellsonics, Matternet, Microsonic Systems, Nanotics, Omniox (also serving as Executive Chair), RenovoRx, and xCures and is an advisor to Assurance Health Data, PharmaJet, and the Precision Medicine World Conference.

Previously, Dr. Marton was Dean of the University of Wisconsin Medical School and Chaired the Department of Laboratory Medicine at UCSF, where he was a Professor in the Departments of Laboratory Medicine and Neurological Surgery.  Dr. Marton received his MD from the Albert Einstein College of Medicine.